Vincent Milano
CIK: 0001187159
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Aug 31, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.2K shares at avg. $9.70$11K - Jun 11, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct15.3K shares- - Jun 5, 2026ACRS
Aclaris Therapeutics, Inc.
Exercise(M)Direct11.6K shares- - Jun 4, 2026ACRS
Aclaris Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
11K shares- - Jun 4, 2026ACRS
Aclaris Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
42.4K shares- - May 29, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.1K shares at avg. $8.91$10K - Feb 27, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct848 shares at avg. $8.75$7K - Nov 28, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct783 shares at avg. $7.18$6K - Aug 29, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct676 shares at avg. $8.31$6K - Jun 12, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct12.5K shares- - Jun 6, 2025ACRS
Aclaris Therapeutics, Inc.
Exercise(M)Direct4.8K shares- - Jun 5, 2025ACRS
Aclaris Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
42.4K shares- - Jun 5, 2025ACRS
Aclaris Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
11.6K shares- - May 30, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct523 shares at avg. $10.75$6K - Feb 28, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct653 shares at avg. $8.61$6K - Nov 29, 2024BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct750 shares at avg. $7.50$6K - Aug 30, 2024BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct647 shares at avg. $8.69$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,159 | $9.70 | $11,242 | Direct |
| Jun 11, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 15,294 | - | $0 | Direct |
| Jun 5, 2026 |  ACRS Aclaris Therapeutics, Inc. | Exercise(M) | 11,580 | - | $0 | Direct |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc. | Award(A) Restricted Stock Units | 10,987 | - | - | Direct |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 42,350 | - | - | Direct |
| May 29, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,122 | $8.91 | $9,997 | Direct |
| Feb 27, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 848 | $8.75 | $7,420 | Direct |
| Nov 28, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 783 | $7.18 | $5,622 | Direct |
| Aug 29, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 676 | $8.31 | $5,618 | Direct |
| Jun 12, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 12,500 | - | - | Direct |
| Jun 6, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise(M) | 4,793 | - | - | Direct |
| Jun 5, 2025 | ACRS Aclaris Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 42,350 | - | - | Direct |
| Jun 5, 2025 | ACRS Aclaris Therapeutics, Inc. | Award(A) Restricted Stock Units | 11,580 | - | - | Direct |
| May 30, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 523 | $10.75 | $5,622 | Direct |
| Feb 28, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 653 | $8.61 | $5,622 | Direct |
| Nov 29, 2024 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 750 | $7.50 | $5,625 | Direct |
| Aug 30, 2024 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 647 | $8.69 | $5,622 | Direct |
1-17 of 17 transactions
About MILANO VINCENT
MILANO VINCENT (SEC CIK 0001187159) files insider reports with the SEC as Director of BIOCRYST PHARMACEUTICALS INC (BCRX) and Director of Aclaris Therapeutics, Inc. (ACRS).
Signal8 holds 13 ownership filings by MILANO VINCENT, all Form 4s, filed between Sep 3, 2024 and Sep 2, 2026. Those filings report 17 transactions, from Aug 30, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MILANO VINCENT's filings is in DURHAM, NC.
Recent filings by MILANO VINCENT
- Aug 31, 2026: Grant or award of BCRX shares (Form 4, code A).
- Jun 11, 2026: Grant or award of BCRX shares (Form 4, code A).
- Jun 5, 2026: Option exercise of ACRS shares (Form 4, code M).
- Jun 4, 2026: Grants or awards of ACRS derivative securities (2 lines, Form 4, code A).
- May 29, 2026: Grant or award of BCRX shares (Form 4, code A).
Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)
- Stonehouse Jon P, Director
- Milne Jill C., Director
- McKee Amy E, Director
- Frank Steven, Director
- Galson Steven K, Director
- LEVIN ALAN G, Director